发明名称 |
Compositions for cell culture and methods of using the same |
摘要 |
Supplementation of the bioflavonoids such as epigallocatechin gallate, rutin, naringin, or genistein into mammalian cell culture media are shown to be effective in reduction of acidic species variants on recombinant antibodies. The demonstrated reduction in acidic species through the use of bioflavonoids, facilitates the manufacturing of a less heterogeneous product with potential improvements in antibody structure and function. |
申请公布号 |
US9416181(B2) |
申请公布日期 |
2016.08.16 |
申请号 |
US201414270675 |
申请日期 |
2014.05.06 |
申请人 |
AbbVie Inc. |
发明人 |
Wang Min;Hossler Patrick M.;McDermott Sean W.;Racicot Christopher;Chemfe Kofi;Fann John |
分类号 |
C12N5/00;C07K16/24;A61K39/395;C07K16/00 |
主分类号 |
C12N5/00 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP |
主权项 |
1. A composition comprising a chemically-defined medium (CDM) and a bioflavonoid selected from the group consisting of epigallocatechin gallate (EGCG), rutin, naringin, and genistein, wherein said bioflavonoid is present in said composition at a concentration ranging from about 0.001 g/L to about 0.2 g/L. |
地址 |
North Chicago IL US |